2022 annual financial data
Aptevo Therapeutics 2022 Net margin
Direct answer
Net margin was 257.77%.
Operating income was -28,641,000 USD and net income was 8,027,000 USD.
Operating cash flow was -21,022,000 USD.
Get free Aptevo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,114,000 USD
- Operating income
- -28,641,000 USD
- Net income
- 8,027,000 USD
- Operating cash flow
- -21,022,000 USD